FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064277 [Registered on: 18/03/2024] Trial Registered Prospectively
Last Modified On: 14/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effectiveness of 4% Articaine as local anaesthetic agent in pediatric dentistry 
Scientific Title of Study   Comparative Evaluation Of Onset Of Action And Efficacy Of 2% Lignocaine And 4% Articaine After Administration Of Local Anaesthesia For Pulp Therapy Of Primary Maxillary Molars In Children Aged 5-10 Years : A Randomized Clinical Trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanika Karmarkar 
Designation  Post Graduate Student 
Affiliation  Department of Pediatric and Preventive Dentistry, KLE VK Institute of dental sciences, Belgaum 
Address  KLE VK Institute of Dental Sciences, JNMC campus Nehru nagar
Belgaum Karnataka
Belgaum
KARNATAKA
590010
India 
Phone  9920896106  
Fax    
Email  sanikakarmarkar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chandrashekhar M Badakar 
Designation  Professor 
Affiliation  Department of Pediatric and Preventive Dentistry, KLE VK Institute of dental sciences, Belgaum 
Address  JNMC campus Nehru nagar
Belgaum Karnataka
Belgaum
KARNATAKA
590010
India 
Phone  9902773259  
Fax    
Email  badakar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanika Karmarkar 
Designation  Post Graduate Student 
Affiliation  Department of Pediatric and Preventive Dentistry, KLE VK Institute of dental sciences, Belgaum 
Address  JNMC campus Nehru nagar
Belgaum Karnataka
Belgaum
KARNATAKA
590010
India 
Phone  9920896106  
Fax    
Email  sanikakarmarkar@gmail.com  
 
Source of Monetary or Material Support  
Dr. Sanika Karmarkar, Department of Pediatric and Preventive Dentistry, KLE VK Institute of Dental Sciences. 
 
Primary Sponsor  
Name  Dr Sanika Karmarkar 
Address  KLE VK Institute of dental sciences, Belagavi 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanika Karmarkar  KLE VK Institute of Dental Sciences  Department of Pediatric and Preventive Dentistry, Department number 6, 1st floor, KLE VK Institute of dental sciences, JNMC campus, Nehru nagar, Belgaum, Karnataka
Belgaum
KARNATAKA 
9920896106

sanikakarmarkar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Research and Ethics Committee KLE VKIDS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: K040||Pulpitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  2% Lignocaine  Local anaesthetic agent. Dosage: 1 ml (maximum permissible dose of 7 mg/kg) given as injection intraorally once before treatment 
Comparator Agent  4% Articaine   Local anaesthetic agent. Dosage: 1 ml (maximum permissible dose of 7 mg/kg) given as injection intraorally once before treatment 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  Patients with maxillary molars requiring pulpectomy treatment 
 
ExclusionCriteria 
Details  Medically compromised patients 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Onset of action of Articaine 4% and Lignocaine 2%(recorded in seconds)  Time will be recorded only once after administration of local anaesthesia 
 
Secondary Outcome  
Outcome  TimePoints 
Efficacy of Articaine 4% & Lignocaine 2%  Measured after access opening of the tooth anaesthetized (once) 
 
Target Sample Size   Total Sample Size="48"
Sample Size from India="48" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   25/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  25/03/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   48 patients, between the ages of 5 to 10 years, requiring pulpectomy treatment for maxillary molars will be recruited for the study. The patients will be randomized into 2 groups, Group A will receive 2% Lignocaine and Group B will receive 4% Articaine as local anaesthetic agents. A skin prick allergy test will be done prior to injection. After a negative test, the child will undergo local anaesthesia administration using the local infiltration method for the tooth to be treated. Measurement of onset of action of both anaesthetic agents will be recorded immediately after needle withdrawal till the appearance of subjective (numbness, tickling) and objective symptoms (gingival probing). The access opening will begin 5 minutes after anaesthesia. Efficacy will be measured immediately after using Wong Bakers Faces pain rating scale and Sound Eye Motor scale. 
Close